United States Patent (19) 11 Patent Number: 6,129,925 Kido Et Al

Total Page:16

File Type:pdf, Size:1020Kb

United States Patent (19) 11 Patent Number: 6,129,925 Kido Et Al USOO6129925A United States Patent (19) 11 Patent Number: 6,129,925 Kido et al. (45) Date of Patent: *Oct. 10, 2000 54 CONTAINER FILLED WITH INFUSION 5,770,233 6/1998 Kido et al. .............................. 424/641 LIQUIDS AND INFUSION PREPARATION FOREIGN PATENT DOCUMENTS 75 Inventors: Takae Kido; Shigeo Ii; Shun-ichi Abe; 0510687 10/1992 European Pat. Off.. Kazumasa Yokoyama, all of Osaka, 58-162515 9/1982 Japan. Japan 58-162517 9/1983 Japan. 61-058560 3/1986 Japan. 73 Assignee: Yoshitomi Pharmaceutical Industries, 62-135421 6/1987 Japan. Ltd., Osaka, Japan OTHER PUBLICATIONS * Notice: This patent issued on a continued pros Derwent Abstract N89-244721, abstracting JP 1-240469, ecution application filed under 37 CFR 1989. 1.53(d), and is subject to the twenty year Chemical Abstracts 99:146124J, 1983. patent term provisions of 35 U.S.C. Chemical Abstracts 69:89709h (1968). 154(a)(2). Primary Examiner S. Mark Clardy Assistant Examiner Kathryne E. Shelborne 21 Appl. No.: 09/032,843 Attorney, Agent, or Firm Sughrue, Mion, Zinn, Macpeak 22 Filed: Mar. 2, 1998 & Seas, PLLC 57 ABSTRACT Related U.S. Application Data An object of the present invention is to provide an infusion 60 Division of application No. 08/437,330, Apr. 21, 1995, Pat. preparation set (a container filled with infusion liquids) No. 5,770,233, which is a continuation-in-part of application useful for preparation of an infusion liquid containing No. PCT/JP93/01521, Oct. 21, 1993. Sugars, amino acids, electrolytes, a fat emulsion and Vita 30 Foreign Application Priority Data mins. The present invention is constituted by the use of a container having two compartments which are separated Oct. 22, 1992 JP Japan .................................... 4-309249 from each other by a separation means, which contains an 51 Int. Cl." .............................. A61K 13/00; A61K 9/66 infusion liquid comprising a fat emulsion, Sugars, fat-Soluble 52 U.S. Cl. .......................... 424/400; 424/422; 424/423; Vitamins and Specified water-Soluble Vitamins in the first 424/455 compartment and an infusion liquid comprising amino acids, 58 Field of Search ..................................... 424/400, 422, electrolytes and other specified water-Soluble Vitamins in the 424/423, 455; 514/937, 943 Second compartment. An infusion preparation containing Sugars, amino acids, electrolytes, a fat emulsion and Vita 56) References Cited mins can be obtained easily and aseptically upon use, by Simply removing a separation means and mixing the infu U.S. PATENT DOCUMENTS Sion liquids included in the first and Second compartments. 4,000,190 12/1976 Mader et al. ........................... 424/127 Further, the components of the infusion liquids included in 5,560,403 10/1996 Balteau et al. .............................. 141/9 each compartment have good Stability. 5,626,880 5/1997 Inoue et al. ... ... 424/489 5,674,527 10/1997 Inoue et al. ............................. 424/450 21 Claims, 3 Drawing Sheets 6,129,925 1 2 CONTAINER FILLED WITH INFUSION tation. In order to prevent the formation of turbidity and LIQUIDS AND INFUSION PREPARATION precipitation, Such an electrolyte infusion liquid is usually adjusted to a low pH value (less than pH 5). When such a CROSS REFERENCE TO RELATED electrolyte infusion liquid is mixed with an amino acid APPLICATIONS infusion liquid, the pH of the mixture increases to the amino acid pH value because of the Strong buffer action of amino This is a continuation-in-part application of PCT Appli acids, thus requiring a large quantity of acidic materials (for cation No. PCT/JP93/01521, filed Oct. 21, 1993. example, hydrochloric acid, acetic acid and the like) to keep This is a divisional of application Ser. No. 08/437,330 the pH value at a low level. However, acidic materials can filed Apr. 21, 1995 now U.S. Pat. No. 5,770,223. be used only in a limited amount because a large quantity of acid Spoils the balance of the infusion components. AS a TECHNICAL FIELD consequence, the pH value of the mixture of electrolyte and This invention relates to infusion preparations which amino acid infusion liquids cannot be lowered to a Satisfac comprise a fat emulsion, Sugars, amino acids, electrolytes tory level, thus resulting in the generation of turbidity and and Vitamins, to a container filled with infusion liquids for 15 precipitation at the time of heat Sterilization of the mixture. use in making Said infusion preparations and infusion liq In addition, when a mixture of an amino acid infusion uids. More specifically, the invention relates to (1) an liquid with a Sugar infusion liquid is Sterilized by heating, infusion preparation comprising a fat emulsion, Sugars and considerable coloring occurs due to the Maillard's reaction. Specific Vitamins, (2) an infusion preparation comprising AS described above, it is difficult to prepare a storable amino acids, electrolytes and other vitamins, (3) a container infusion preparation which contains a Sugar, amino acids, filled with infusion preparations in which the above infusion electrolytes and a fat emulsion, in advance, because mixing preparations (1) and (2) are contained in the respective these different types of infusion liquids or emulsions causes compartments, and (4) an infusion preparation prepared by various problems Such as precipitation, denaturation, color mixing infusion liquids contained in the respective compart ing and the like. Because of these problems, a fat emulsion, mentS. 25 a Sugar infusion liquid, an amino acid infusion liquid and an electrolyte infusion liquid are ordinarily mixed upon use. AS BACKGROUND ART a consequence, an infusion preparation has been desired Intravenous infusion is carried out for the purpose of which contains Sugars, amino acids, electrolytes and a fat Supplying nutrients to maintain a patient's life when oral or emulsion and can be stably Stored. nasal feeding is impossible or insufficient, when the diges Under these circumstances, the present inventors have tion and absorption functions of the patient are in a poor conducted intensive Studies on the development of a prepa State, even if Such a feeding means can be carried out, or ration method of a Stable infusion preparation which con when the passage of food through the digestive tract makes tains Sugars, amino acids, electrolytes and a fat emulsion. the patient's condition or disease more Serious. Examples of They have found that preparations containing the above commercially available infusion preparations include a 35 components in a certain combination can be stably Stored Sugar intravenous infusion which contains reducing Sugars and an infusion preparation containing Sugars, amino acids, and the like, amino acids and the like, an electrolyte infusion electrolytes and a fat emulsion can be easily obtained, upon liquid which contains electrolytes and the like, a fat emul use, without Suffering from precipitation, denaturation, col Sion which contains a plant oil and the like, and a vitamin oring and other problems. More specifically, it has been mixture. These infusion preparations are appropriately 40 found that the above problems can be Solved by putting an Selected depending on the condition of the patient and are infusion liquid containing a fat emulsion and Sugars into the mixed upon use. However, mixing these preparations at the first compartment of a container having two compartments time of their use requires complex handling and, above all which are separated by a separation means, putting an things, raises the problem of microbial contamination. With infusion liquid containing amino acids and electrolytes into the aim of overcoming Such problems, various infusion 45 its Second compartment, Sterilizing Said container, preserv preparations, in which Some of the aforementioned infusion ing it in this State, and mixing the infusion liquids contained liquids are mixed in advance, have been proposed. Infusion in the first compartment and the Second compartment by preparations which contain Sugars, amino acids, electrolytes removing the separation means upon use (cf. JP-A-5- and a fat emulsion, all being essential nutrients to be 50 31151). Supplied, are especially useful from a clinical point of view. It has become common to give various vitamins during However, Since these Sugar infusion liquids, amino acid treatment with total parenteral nutrition (TPN). In this infusion liquids, electrolyte infusion liquids and fat emul instance, vitamins are added to TPN admixture upon clinical Sion are different from one another in terms of the conditions use. In order to further improve the above-described newly for their stable existence, various problems arise when they 55 developed infusion preparation containing Sugars, amino are mixed, and the mixture becomes useleSS in many cases. acids, electrolytes and a fat emulsion, it is desirable to For example, because of its unstable nature, a fat emul develop TPN admixture in a more perfect form containing Sion is apt to form bulky fat particles and to cause phase Vitamins, in advance, thereby Saving the Step of adding Separation (creaming) when mixed with other infusion liq Vitamins upon clinical use. uids. In particular, divalent cations contained in an electro 60 However, Vitamins are usually unstable and a certain lyte infusion liquid cause aggregation and disintegration of combination of Vitamins can cause decomposition of one of fat emulsion particles. the Vitamins or can make the liquid turbid. For example, the In the case of an electrolyte infusion liquid, Since it present inventors have found that the Solution becomes contains calcium and phosphoric acid as essential compo turbid when folic acid is mixed with vitamin C, and that nents to maintain the balance of electrolytes, it is apt to form 65 Vitamin C promotes decomposition of Vitamin B. calcium phosphate by the reaction of calcium with phos Therefore, it is necessary to pay attention to the combination phoric acid and therefore to generate turbidity and precipi use of vitamins. Vitamins are roughly divided into two 6,129,925 3 4 groups: a water-Soluble group and a fat-Soluble group.
Recommended publications
  • Guidelines on Food Fortification with Micronutrients
    GUIDELINES ON FOOD FORTIFICATION FORTIFICATION FOOD ON GUIDELINES Interest in micronutrient malnutrition has increased greatly over the last few MICRONUTRIENTS WITH years. One of the main reasons is the realization that micronutrient malnutrition contributes substantially to the global burden of disease. Furthermore, although micronutrient malnutrition is more frequent and severe in the developing world and among disadvantaged populations, it also represents a public health problem in some industrialized countries. Measures to correct micronutrient deficiencies aim at ensuring consumption of a balanced diet that is adequate in every nutrient. Unfortunately, this is far from being achieved everywhere since it requires universal access to adequate food and appropriate dietary habits. Food fortification has the dual advantage of being able to deliver nutrients to large segments of the population without requiring radical changes in food consumption patterns. Drawing on several recent high quality publications and programme experience on the subject, information on food fortification has been critically analysed and then translated into scientifically sound guidelines for application in the field. The main purpose of these guidelines is to assist countries in the design and implementation of appropriate food fortification programmes. They are intended to be a resource for governments and agencies that are currently implementing or considering food fortification, and a source of information for scientists, technologists and the food industry. The guidelines are written from a nutrition and public health perspective, to provide practical guidance on how food fortification should be implemented, monitored and evaluated. They are primarily intended for nutrition-related public health programme managers, but should also be useful to all those working to control micronutrient malnutrition, including the food industry.
    [Show full text]
  • Potato - Analysis of Nutrients by Veronica Öhrvik, Irene Mattisson, Sören Wretling and Christina Åstrand
    Rapport 19 − 2010 Potato - analysis of nutrients by Veronica Öhrvik, Irene Mattisson, Sören Wretling and Christina Åstrand LIVSMEDELS VERKET NATIONAL FOOD ADMINISTRATION, Sweden Content Summary .................................................................................................................................... 2 Background ................................................................................................................................ 3 Materials and methods ............................................................................................................... 4 Sampling potatoes .................................................................................................................. 4 Varieties ............................................................................................................................. 4 Geographical distribution ................................................................................................... 5 Catering potato ................................................................................................................... 5 Sample handling ..................................................................................................................... 7 Quality assurance of analytical methods ................................................................................ 8 Analysed nutrients .................................................................................................................. 9 Calculation of nutritional
    [Show full text]
  • |||||||||||||III US005202354A United States Patent (19) (11) Patent Number: 5,202,354 Matsuoka Et Al
    |||||||||||||III US005202354A United States Patent (19) (11) Patent Number: 5,202,354 Matsuoka et al. 45) Date of Patent: Apr. 13, 1993 (54) COMPOSITION AND METHOD FOR 4,528,295 7/1985 Tabakoff .......... ... 514/562 X REDUCING ACETALDEHYDE TOXCTY 4,593,020 6/1986 Guinot ................................ 514/811 (75) Inventors: Masayoshi Matsuoka, Habikino; Go OTHER PUBLICATIONS Kito, Yao, both of Japan Sprince et al., Agents and Actions, vol. 5/2 (1975), pp. 73) Assignee: Takeda Chemical Industries, Ltd., 164-173. Osaka, Japan Primary Examiner-Arthur C. Prescott (21) Appl. No.: 839,265 Attorney, Agent, or Firn-Wenderoth, Lind & Ponack 22) Filed: Feb. 21, 1992 (57) ABSTRACT A novel composition and method are disclosed for re Related U.S. Application Data ducing acetaldehyde toxicity, especially for preventing (63) Continuation of Ser. No. 13,443, Feb. 10, 1987, aban and relieving hangover symptoms in humans. The com doned. position comprises (a) a compound of the formula: (30) Foreign Application Priority Data Feb. 18, 1986 JP Japan .................................. 61-34494 51) Int: C.5 ..................... A01N 37/00; A01N 43/08 52 U.S. C. ................................. ... 514/562; 514/474; 514/81 wherein R is hydrogen or an acyl group; R' is thiol or 58) Field of Search ................ 514/557, 562, 474,811 sulfonic group; and n is an integer of 1 or 2, (b) ascorbic (56) References Cited acid or a salt thereof and (c) a disulfide type thiamine derivative or a salt thereof. The composition is orally U.S. PATENT DOCUMENTS administered, preferably in the form of tablets. 2,283,817 5/1942 Martin et al.
    [Show full text]
  • Cytokinins / Coconut Water
    Molecules 2009, 14, 5144-5164; doi:10.3390/molecules14125144 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review The Chemical Composition and Biological Properties of Coconut (Cocos nucifera L.) Water Jean W. H. Yong, Liya Ge, Yan Fei Ng and Swee Ngin Tan * Natural Sciences and Science Education Academic Group, Nanyang Technological University, 1 Nanyang Walk, 637616 Singapore * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +65-6790 3810; Fax: +65-6896 9432. Received: 3 November 2009; in revised form: 3 December 2009 / Accepted: 8 December 2009 / Published: 9 December 2009 Abstract: Coconut water (coconut liquid endosperm), with its many applications, is one of the world’s most versatile natural product. This refreshing beverage is consumed worldwide as it is nutritious and beneficial for health. There is increasing scientific evidence that supports the role of coconut water in health and medicinal applications. Coconut water is traditionally used as a growth supplement in plant tissue culture/micropropagation. The wide applications of coconut water can be justified by its unique chemical composition of sugars, vitamins, minerals, amino acids and phytohormones. This review attempts to summarise and evaluate the chemical composition and biological properties of coconut water. Keywords: coconut water; phytohormone; auxin; cytokinin; gibberellin; inorganic ion; vitamin 1. Introduction The coconut (Cocos nucifera L.) is an important fruit tree in the tropical regions and the fruit can be made into a variety of foods and beverages (Figure 1). The edible part of the coconut fruit (coconut meat and coconut water) is the endosperm tissue.
    [Show full text]
  • Circulatory and Urinary B-Vitamin Responses to Multivitamin Supplement Ingestion Differ Between Older and Younger Adults
    nutrients Article Circulatory and Urinary B-Vitamin Responses to Multivitamin Supplement Ingestion Differ between Older and Younger Adults Pankaja Sharma 1,2 , Soo Min Han 1 , Nicola Gillies 1,2, Eric B. Thorstensen 1, Michael Goy 1, Matthew P. G. Barnett 2,3 , Nicole C. Roy 2,3,4,5 , David Cameron-Smith 1,2,6 and Amber M. Milan 1,3,4,* 1 The Liggins Institute, University of Auckland, Auckland 1023, New Zealand; [email protected] (P.S.); [email protected] (S.M.H.); [email protected] (N.G.); [email protected] (E.B.T.); [email protected] (M.G.); [email protected] (D.C.-S.) 2 Riddet Institute, Palmerston North 4474, New Zealand; [email protected] (M.P.G.B.); [email protected] (N.C.R.) 3 Food & Bio-based Products Group, AgResearch, Palmerston North 4442, New Zealand 4 High-Value Nutrition National Science Challenge, Auckland 1023, New Zealand 5 Department of Human Nutrition, University of Otago, Dunedin 9016, New Zealand 6 Singapore Institute for Clinical Sciences, Agency for Science, Technology, and Research, Singapore 117609, Singapore * Correspondence: [email protected]; Tel.: +64-(0)9-923-4785 Received: 23 October 2020; Accepted: 13 November 2020; Published: 17 November 2020 Abstract: Multivitamin and mineral (MVM) supplements are frequently used amongst older populations to improve adequacy of micronutrients, including B-vitamins, but evidence for improved health outcomes are limited and deficiencies remain prevalent. Although this may indicate poor efficacy of supplements, this could also suggest the possibility for altered B-vitamin bioavailability and metabolism in older people.
    [Show full text]
  • Pyridoxamine: a Novel Treatment for Schizophrenia with Enhanced Carbonyl Stress
    Psychiatry and Clinical Neurosciences 2018; 72:35–44 doi:10.1111/pcn.12613 Regular Article Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress , ,† ,† Masanari Itokawa, MD, PhD,1,2,3 * Mitsuhiro Miyashita, MD, PhD ,1,2,4 Makoto Arai, PhD,1 Takashi Dan, MD, PhD,5 Katsuyoshi Takahashi, MD, PhD,2 Taro Tokunaga, MD,2 Kayo Ishimoto, MD,2 Kazuya Toriumi, PhD,1 Tomoe Ichikawa, PhD,1 Yasue Horiuchi, PhD,1 Akiko Kobori, MS,1 Satoshi Usami, PhD,6 Takeo Yoshikawa, MD, PhD,3 Naoji Amano, MD, PhD,4 Shinsuke Washizuka, MD, PhD,4 Yuji Okazaki, MD2 and Toshio Miyata, MD, PhD5 1Project for Schizophrenia Research, Tokyo Metropolitan Institute of Medical Science, 2Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Tokyo, 3Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, 4Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, 5Division of Molecular Medicine and Therapy, Tohoku University Graduate School of Medicine, Sendai, and 6Graduate School of Education, University of Tokyo, Tokyo, Japan Aim: The aim of this clinical trial was to obtain considerable reduction in psychosis accompanied proof of concept for high-dose pyridoxamine as a with a moderate decrease in plasma pentosidine novel treatment for schizophrenia with enhanced levels. A reduction of greater than 20% in the carbonyl stress. assessment scale of drug-induced Parkinsonism occurred in four patients. Although there was no Methods: Ten Japanese schizophrenia patients with severe suicide-related ideation or behavior, Wer- high plasma pentosidine, which is a representative nicke’s encephalopathy-like adverse drug reactions biomarker of enhanced carbonyl stress, were recruited occurred in two patients and were completely sup- in a 24-week, open trial in which high-dose pyridox- pressed by thiamine supplementation.
    [Show full text]
  • Dietary Supplements Compendium Volume 1
    2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs .
    [Show full text]
  • LYSOVIT® (B-Complex+Lysine)
    Lysovit/LPD/PK-02 LYSOVIT® (B-Complex+Lysine) 1. NAME OF THE MEDICINAL PRODUCT LYSOVIT® 2. QUALITATIVE AND QUANTITATIVE COMPOSITION LYSOVIT® Syrup 120 ml Description Each 5 ml contains: Thiamine HCl 4.16 mg Riboflavin USP 1.66 mg Pyridoxine HCl 1 mg Niacinamide USP 18 mg D-Panthenol USP 2.5 mg Cyanocobalamin USP 8.33 mcg Ascorbic Acid USP 75 mg Inositol USP 5 mg Lysine Monohydrochloride USP 33.33 mg 3. PHARMACEUTICAL FORM Syrup 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS 1. For maintenance of health and to meet the extra energy needs of growing children. 2. Increases appetite and helps in recovery from illnesses. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Children: 1 teaspoonful daily or as prescribed by the physician Adults: One to two teaspoonsful daily. Shake well before use. Thiamine Benefits: Thiamine is recommended for digestive problems including poor appetite, ulcerative colitis, and ongoing diarrhea. People take thiamine for conditions related to low levels of thiamine (thiamine deficiency syndromes), including beriberi and inflammation of the nerves (neuritis) associated with pellagra or pregnancy.4 1 Lysovit/LPD/PK-02 Thiamine - Daily Recommended Dietary Allowance (RDA): In adults, 1-2 mg of thiamine per day is commonly used. Infants 0-6 months, 0.2 mg Infants 7-12 months, 0.3 mg Children 1-3 years, 0.5 mg Children 4-8 years, 0.6 mg Boys 9-13 years, 0.9 mg Men 14 years and older, 1.2 mg4 Girls 9-13 years, 0.9 mg Women 14-18 years, 1 mg Women over 18 years, 1.1 mg Pregnant women, 1.4 mg Breast-feeding women, 1.5 mg Riboflavin Benefits: Riboflavin had a direct impact on maintenance of good brain function.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7.625,916 B2 Kawasugi (45) Date of Patent: Dec
    US00762.5916B2 (12) United States Patent (10) Patent No.: US 7.625,916 B2 Kawasugi (45) Date of Patent: Dec. 1, 2009 (54) MEDICINAL COMPOSITION (56) References Cited (76) Inventor: Kaname Kawasugi, 26-10-405, U.S. PATENT DOCUMENTS Higashi-oi 5-chome, Shinagawa-ku 3,502,674. A 3/1970 Takamizawa et al. Tokyo (JP) 140-0011 4,687,777 A * 8/1987 Meguro et al. .............. 514,342 5,002.953 A * 3/1991 Hindley ......... ... 514,275 c - r 5,977.073 A * 1 1/1999 Khaled ........................ 514, 19 (*) Notice: Subject to any disclaimer, the term of this 6,166,219 A * 12/2000 Yamasaki et al. ........ 548/309.4 patent is extended or adjusted under 35 6.251926 B1* 6/2001 Momose et al. ............. 514,364 U.S.C. 154(b) by 122 days. 6,660,293 B2 * 12/2003 Giordano et al. ............ 424/439 (21) Appl. No.: 10/572,557 FOREIGN PATENT DOCUMENTS FR 2832O64 A1 * 5, 2003 (22) PCT Filed: Sep. 17, 2003 WO O2/O51441 T 2002 (86). PCT No.: PCT/UP03/11847 OTHER PUBLICATIONS Tamai, Hiroshi. “Diabetes and Vitamin Levels', Japanese Journal of S371 (c)(1), Clinical Medicine, vol. 57, No. 10, pp. 200-203, 1999. (2), (4) Date: Mar. 17, 2006 Hashizume, Naotaka, “Vitamin B1 Deficiency”. Igaku no Ayumi, vol. 198, No. 13, pp. 949-952, 2001. (87) PCT Pub. No.: WO2005/027967 * cited by examiner PCT Pub. Date: Mar. 31, 2005 Primary Examiner Kevin Weddington (74) Attorney, Agent, or Firm Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. (65) Prior Publication Data (57) ABSTRACT US 2007/O 10591.0 A1 May 10, 2007 A medicinal composition which comprises an insulin resis 51) Int.
    [Show full text]
  • Sensitive and Cost-Effective Detection of B Vitamins in Foods by UHPLC/MS/MS
    Rapid, Sensitive and Cost-effective Detection of B Vitamins in Foods by UHPLC/MS/MS Application Note Food Testing Author Abstract Nick Byrd A fast UHPLC/MS/MS method has been developed on the Agilent 1290 Infinity LC Campden BRI System coupled to the Agilent 6460 Triple Quadrupole LC/MS System with Agilent Jet Chipping Campden, Gloucestershire Stream technology for the extraction and determination of five B vitamins in foods. United Kingdom The method has a sensitivity of at least 1 µg/kg for all six vitamins. Introduction The B vitamins play important roles in cell metabolism and in promoting human health. They are water soluble and not stored very well by the body, necessitating daily intake through diet or nutritional supplements. Deficiencies of one or more of the B vitamins may occur fairly easily, especially during times of fasting or weight- loss diets or with diets that include substantial amounts of refined and processed food, sugar, or alcohol. The germ and bran of cereal grains are good sources of these vitamins, as are some beans, peas, and nuts. Milk and many leafy green vegetables may also supply small amounts of B vitamins. While most of the B vitamins are not harmful when ingested at high amounts, B3 and B6 can, in fact, be toxic at high concentrations, leading to neuropathy and excessive blood vessel dilation. To ensure safe levels of vitamins in foods and nutritional supplements, the European Union (EU) has put in place Regulation No. 1925/2006, specifing which vitamins can be added to foods, which foods can and cannot be fortified with vitamins, and minimum and maximum levels for vitamins in foods.
    [Show full text]
  • Pyridoxine (Pyridoxamine) 5'-Phosphate Oxidase In
    PYRIDOXINE (PYRIDOXAMINE) 5’-PHOSPHATE OXIDASE IN ARABIDOPSIS THALIANA Except where reference is made to the work of others, the work described in this dissertation is my own or was done in collaboration with my advisory committee. This dissertation does not include proprietary or classified information. Yuying Sang Certificate of Approval: Robert D. Locy Narendra K. Singh, Chair Professor Professor Biological Sciences Biological Sciences Joe H. Cherry Joanna Wysocka-Diller Emeritus Professor Associate Professor Biological Sciences Biological Sciences Fenny Dane George T. Flowers Professor Dean Horticulture Graduate School PYRIDOXINE (PYRIDOXAMINE) 5’-PHOSPHATE OXIDASE IN ARABIDOPSIS THALIANA Yuying Sang A Dissertation Submitted to the Graduate Faculty of Auburn University in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Auburn, Alabama December 19, 2008 PYRIDOXINE (PYRIDOXAMINE) 5’-PHOSPHATE OXIDASE IN ARABIDOPSIS THALIANA Yuying Sang Permission is granted to Auburn University to make copies of this dissertation at its discretion, upon request of individuals of institutions and at their expense. The author reserves all publication right. Signature of Author Date of Graduation iii VITA Yuying Sang, daughter of Shiqing Sang and Guilan Wang, was born on January 7, 1975, in Chiping, Shandong, People’s Republic of China. She received the Bachelor of Science degree in Biology in July 1997 from Shandong Normal University and entered the Graduate School of Kunming Institute of Botany, Chinese Academy of Sciences. In the July of 2000, she graduated with a Master of Science degree in Botany and joined East China University of Science and Technology as a lab manager in the Department of Bioengineering.
    [Show full text]
  • Water-Soluble Vitamins: B-Complex and Vitamin C Fact Sheet No
    Water-Soluble Vitamins: B-Complex and Vitamin C Fact Sheet No. 9.312 Food and Nutrition Series|Health by L. Bellows and R. Moore* What are Vitamins? and their influence is felt in many parts of Quick Facts Vitamins are essential nutrients found the body. They function as coenzymes that • B-complex vitamins and in foods. They perform specific and vital help the body obtain energy from food. The vitamin C are water-soluble functions in a variety of body systems, and B vitamins are also important for normal are crucial for maintaining optimal health. appetite, good vision, and healthy skin, vitamins that are not stored The two different types of vitamins nervous system, and red blood cell formation. in the body and must be are fat-soluble vitamins and water-soluble Thiamin: Vitamin B1 replaced each day. vitamins. Fat-soluble vitamins — vitamins What is Thiamin. Thiamin, or vitamin B1, • These vitamins are easily A, D, E and K — dissolve in fat before they helps to release energy from foods, promotes destroyed or washed out are absorbed in the bloodstream to carry out normal appetite, and is important in during food storage and their functions. Excesses of these vitamins maintaining proper nervous system function. are stored in the liver, and are not needed Food Sources for Thiamin. Sources preparation. every day in the diet. For more information include peas, pork, liver, and legumes. Most • The B-complex group is on fat-soluble vitamins, see fact sheet 9.315 commonly, thiamin is found in whole grains found in a variety of foods: Fat-Soluble Vitamins: A, D, E, and K.
    [Show full text]